Drug intelligence / Profile preview

Rematin Plus

Development stage: Unknown
Lead developer: Waterley Pharmaceuticals
Modality: Peptides
Administration: Oral

Overview

Rematin Plus is a peptide-based nutritional supplement developed by Waterley Healthcare for the management of gastrointestinal (GI) disorders and the improvement of GI tolerance. Formulated as a peptide powder, it provides hydrolyzed proteins that are more readily absorbed by the intestinal mucosa than intact proteins, thereby reducing the digestive burden on patients with compromised GI function. It is intended for use in clinical nutrition settings for individuals with malabsorption syndromes or other digestive impairments requiring easily absorbable nutrient sources.

Brand names: Rematin Plus
Other names: Rematin Plus Peptide PowderPeptide Powder - Nutritional Supplement for GI Tolerance

Beyond the preview

Go deeper on Rematin Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rematin Plus.

Explore the full profile